| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |